These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 485704)

  • 21. Role of saline consumption in the prevention of deoxycorticosterone hypertension in rats by central 6-hydroxydopamine.
    Lewis PJ; Dargie HJ; Dollery CT
    Clin Sci Mol Med; 1975 Apr; 48(4):327-30. PubMed ID: 1126124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral intraventricular 6-hydroxydopamine prevents vascular changes in the mineralocorticoid hypertensive rat.
    Mecca TE; Lamb FS; Hall JL; Webb RC
    Proc Soc Exp Biol Med; 1985 Jun; 179(2):248-53. PubMed ID: 3921975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the role of the septal area in the development of DOCA-salt hypertension in the rat.
    Richardson JS
    Clin Exp Hypertens A; 1983; 5(3):469-78. PubMed ID: 6839515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased pressor responses to nicotine in spontaneously hypertensive rats.
    Kubo T; Misu Y
    Jpn J Pharmacol; 1981 Apr; 31(2):221-6. PubMed ID: 7311140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged effects of p-chlorophenylalanine on the blood pressure of conscious normotensive and DOCA/saline hypertensive rats.
    Buckingham RE; Hamilton TC; Moore RA
    Br J Pharmacol; 1976 Jan; 56(1):69-75. PubMed ID: 130177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated development of hypertension by chronic administration of bromocriptine in Doca-salt hypertensive rats.
    Kambara S; Yoshimura M; Okabayashi H; Takahashi H; Ijichi H
    Jpn Circ J; 1986 Nov; 50(11):1120-7. PubMed ID: 3102804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of intracisternal 6-hydroxydopamine and of subsequent lesions of the ventrolateral medulla coinciding with the Al group of noradrenaline cells in the rabbit.
    Elliott JM; Stead BH; West MJ; Chalmers J
    J Auton Nerv Syst; 1985; 12(2-3):117-30. PubMed ID: 3923089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-hypertensive effects of propranolol unaltered by 6-hydroxydopamine given intraventricularly to SHR.
    Kubo T; Misu Y
    Jpn J Pharmacol; 1981 Apr; 31(2):286-8. PubMed ID: 6273626
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular responses of conscious DOCA-salt hypertensive rats to acute intracerebroventricular and intravenous administration of captopril.
    Pochiero M; Nicoletta P; Losi E; Bianchi A; Caputi AP
    Pharmacol Res Commun; 1983 Feb; 15(2):173-82. PubMed ID: 6342005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Centrally-induced vasopressor responses to carbachol are augmented in DOCA-salt hypertensive rats.
    Takahashi H; Inoue A; Takeda K; Okajima H; Sasaki S; Iyoda I; Yoshimura M; Nakagawa M; Ijichi H
    Cardiovasc Res; 1984 Feb; 18(2):126-32. PubMed ID: 6697339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Periventricular noradrenergic systems are critical for angiotensin-induced drinking and blood pressure responses.
    Bellin SI; Bhatnagar RK; Johnson AK
    Brain Res; 1987 Feb; 403(1):105-12. PubMed ID: 3103860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Onset of hypertension in spontaneously hypertensive rats despite the depletion of spinal cord catecholamines.
    Loewy AD; McKellar S; Swensson EE; Panneton WM
    Brain Res; 1980 Mar; 185(2):449-54. PubMed ID: 7357439
    [No Abstract]   [Full Text] [Related]  

  • 33. Propranolol in DOCA hypertensive rats: development of hypertension inhibited and pressor responsiveness enhanced.
    Buñag RD
    Eur J Pharmacol; 1977 Jun; 43(4):323-31. PubMed ID: 880980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of dopamine in the development of spontaneous hypertension.
    van den Buuse M; Versteeg DH; de Jong W
    Hypertension; 1984; 6(6 Pt 1):899-905. PubMed ID: 6519747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of N,N-dimethyl-p-methoxyphenylethylamine on blood pressure and brain catecholamines in DOCA-saline hypertensive rats.
    Shalita B; Versteeg DH; De Jong W
    Eur J Pharmacol; 1982 Nov; 85(2):229-32. PubMed ID: 7151870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of sodium, sympathetic innervation, and central adrenergic structures on renal vascular responsiveness in DOCA-treated rats.
    Berecek KH; Murray RD; Gross F
    Circ Res; 1980 Nov; 47(5):675-83. PubMed ID: 7418127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamic responsiveness in DOCA hypertensive rats augmented by streptozotocin-induced diabetes.
    Sasaki S; Buñag RD
    J Cardiovasc Pharmacol; 1982; 4(6):1042-8. PubMed ID: 6185770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced depressor effect of centrally administered high-calcium solution in salt-loaded experimental hypertension.
    Ozeki S; Seto S; Nagao S; Kusano S; Kitamura S; Oda S; Akahoshi M; Yano K
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):755-62. PubMed ID: 9234656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central noradrenergic neurons and the hypertensive effects of intracerebroventricularly administered prostaglandin E2 in anaesthetized rabbits.
    Otorii T; Ohkubo K; Suzuki K
    Prostaglandins; 1985 Jan; 29(1):25-33. PubMed ID: 3919422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of intraventricular 6-hydroxydopamine on body temperature and arterial blood pressure in cats and rabbits.
    Lewis PJ; Rawlins MD; Reid JL
    Br J Pharmacol; 1974 Jun; 51(2):207-12. PubMed ID: 4451740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.